WealthchartX

IRFC Share Analysis: Is Indian Railway Finance Corporation a Good Buy After the OFS Crash? WealthChartX Desk  |  June 27, 2026  |  Stock Analysis · NSE: IRFC Shares of Indian Railway Finance Corporation (IRFC) have come under sharp selling pressure this week after the Government of India launched a fresh Offer for Sale (OFS) to pare its stake in the Navratna PSU. For long-term investors and traders alike, the question on everyone's mind is simple: is this dip a buying opportunity, or a sign of more pain ahead? What Triggered the Fall On June 24, 2026, the Centre opened a two-day OFS to divest up to 2% of its stake in IRFC, with a floor price fixed at ₹91 per share — roughly a 7.5–8% discount to the previous closing price of around ₹98. The stock reacted instantly, falling over 5–6% on day one as non-retail investors began bidding. The selling didn't stop there. On June 25, with ...

Stock Analysis • Renewable Energy • NSE: SUZLON Suzlon Energy Limited: Can India's Wind Energy Leader Sustain Its Earnings Momentum? ISIN: INE040H01021  |  NSE/BSE: SUZLON  |  Sector: Capital Goods - Electrical Equipment CMP (24 Jun '26) ₹57.91 Market Cap ₹79,464 Cr 52W Range ₹38.19 - ₹68.30 TTM P/E ~25.9x 1Y Return -15% to -17% Suzlon Energy has spent the last few years rebuilding its reputation from a debt-laden turnaround story into one of the more closely watched compounders in India's renewable energy basket. With FY26 results now in and the wind energy policy narrative firming up, it's a good time to take a structured look at where the company stands, what's driving the numbers, and what risks remain on the table....

Crypto Analysis BTC/USD Market Update: 17% Crash, $60K Battle & What Comes Next Bitcoin has shed over 51% from its all-time high and is testing a critical support zone. Here's a full breakdown of the current setup, the forces driving the decline, and key levels traders must watch. 📅 June 7, 2026 | ⏱ 6 min read | WealthChartX 📊 Live Snapshot — June 7, 2026 Current Price ~$60,700 7-Day Change −17% From ATH ($126,080) −51.7% 24H Range $59,496 – $61,464 24H Volume ~$15.8B Market Cap ~$1.21T The Big Picture: Where Bitcoin Stands Right Now Bitcoin is at an inflection point. After touching an all-time high of $126,080 earlier in the cycle, BTC/USD has since entere...

  Deep Dive · Travel & OTA Sector EasyMyTrip (EASEMYTRIP): India's 2nd Largest OTA Is Losing Its Edge — Here's What the Numbers Say From 63% ROCE to near-zero in four years. From India's fastest-growing travel portal to its first-ever annual net loss. A data-driven breakdown of what went wrong — and whether a recovery is possible. ₹6.74 CMP (05 Jun) -39% 1-Year Return ₹2,686 Cr Market Cap -₹48 Cr FY26 Net Profit WealthChartX Verdict EasyMyTrip is a structurally challenged business going through a painful margin reset. The stock has corrected 39% in a year and trades at ~3× book despite a loss year. We are watchlist-only at current levels — the data does not yet support a buy thesis. This article explains why. 1. The Business: What EasyMyTrip Actually...

Stock Analysis · Small Cap Pharma Kwality Pharmaceuticals: 100% Rally & Still Running? A deep dive into NSE's buzzing small-cap pharma play — valuations, risks & what to do now WealthChartX · May 2026 · 5 min read CMP ~₹1,720 Kwality Pharmaceuticals has been one of the more electrifying small-cap stories of the past year — doubling in price while most of the market played cautious. But with fresh all-time highs and a premium valuation, the question every investor is asking is: is this a hold, a buy, or time to step back? ~100%+ 1-Year Return 30–40x P/E Ratio ₹1,700–1,780 Recent ATH Zone The Bull Case — What's Driving the Rally Kwality Pharma's rise isn't just a momentum trade. The fundamentals have genuinely improved. Revenue and profit have jumped sharply over the last few quarters, driven largely by a growing pharma export book. With India's pharma sector gaining global momentum — particularly in generic formulations for regulated markets — Kwality appears...